| High-performance immunoaffinity chromatography, an immunoaffinity membrane for selective removal of plasma components, and safety evaluation of the latter system. | |
| | |
MedLine Citation:
|
PMID: 11694282 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This article reviews our studies on evaluating the suitability of high-performance immunoaffinity chromatography (HPIAC), an immunoaffinity membrane (IAM) for removing unwanted plasma component, and the safety of the IAM. In an attempt to resolve the problem of amyloid deposition in dialysis patients, we used an HPIAC column, bearing anti-beta 2-microglobulin to remove specifically beta 2-MG from human plasma. The use of a membrane as an affinity ligand support was also studied. A specific antibody immobilized on the membrane was highly effective for the removal of rat immunoglobulin E and of a human serum amyloid P component passed through an extracorporeal circulation (EC) system. Biocompatibility of the specific antibody-bearing IAM was also examined. These techniques should prove useful for medical applications and may have broad applicability to the elimination of any unwanted plasma component. The IAM exerts two functions simultaneously, usual dialysis and elimination by immunoaffinity binding. The rat EC model has been applied as an evaluation system for the safety of medical devices in contact with the blood stream. Combining commonly used hemodialysis (HD) membranes with rat EC, we evaluated the elicitation of immunological responses, as well as the effect of repeated EC. The data suggest that this EC model can reproduce similar immunological responses in HD patients, and can be employed to evaluate medical devices and materials for their delayed, systemic, and repeated exposure effects. The EC system described here can reproduce human HD treatment, remove unwanted substances, and evaluate medical devices and materials for toxicological responses. |
| | |
Authors:
|
K Kojima |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of biochemical and biophysical methods Volume: 49 ISSN: 0165-022X ISO Abbreviation: J. Biochem. Biophys. Methods Publication Date: 2001 Oct |
Date Detail:
|
Created Date: 2001-11-05 Completed Date: 2002-01-16 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7907378 Medline TA: J Biochem Biophys Methods Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 241-51 Citation Subset: IM |
Affiliation:
|
Food and Drug Safety Center, Hatano Research Institute, 729-5 Ochiai Hadano, Kanagawa 257-8523, Japan. kojima.k@fdsc.or.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Chemical Analysis / methods* Chromatography, Affinity / methods* Extracorporeal Circulation Humans Immunoglobulin E / blood, isolation & purification Indicators and Reagents Rats Renal Dialysis / methods Safety beta 2-Microglobulin / blood, isolation & purification |
| Chemical | |
Reg. No./Substance:
|
0/Indicators and Reagents; 0/beta 2-Microglobulin; 37341-29-0/Immunoglobulin E |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Affinity membrane chromatography for the analysis and purification of proteins.
Next Document: Multi-analyte analysis of biological fluids with a recycling immunoaffinity column array.